Navigation Links
Palatin Technologies, Inc. to Present at the 24th Annual Piper Jaffray Healthcare Conference
Date:11/20/2012

CRANBURY, N.J., Nov. 20, 2012 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE MKT: PTN) announced that it will be presenting at the 24th Annual Piper Jaffray Healthcare Conference on Tuesday, November 27, 2012 at 3:10 p.m. Eastern Time.  The conference will be held at The New York Plaza, New York.

Carl Spana, Ph.D., President and Chief Executive Officer of Palatin Technologies, will provide an update on Palatin's corporate and development programs.  A live audio broadcast will be available on the "Investors" section of Palatin's website at www.palatin.com. The live audio broadcast will be available through December 3, 2012.

About Palatin Technologies, Inc.
Palatin Technologies, Inc. is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential.  For additional information regarding Palatin, please visit Palatin's website at http://www.palatin.com


'/>"/>
SOURCE Palatin Technologies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Palatin Technologies, Inc. to Report Fiscal Year 2012 First Quarter Results; Teleconference and Webcast to be held on November 15, 2011
2. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011
3. Palatin Technologies to Present at Windhovers Therapeutic Area Partnerships Conference
4. Palatin Technologies, Inc. to Present at the 24th Annual ROTH OC Growth Stock Conference
5. Palatin Technologies, Inc. To Report Fiscal Year 2012 Third Quarter Results; Teleconference and Webcast to be held on May 14, 2012
6. Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on May 14, 2012
7. Palatin Technologies Announces Halting of Phase I Clinical Trial of Obesity Compound in AstraZeneca Research Collaboration
8. Palatin Technologies, Inc. Announces Pricing of $35 Million Private Placement of Common Stock and Warrants
9. Palatin Technologies, Inc. To Report Fiscal Year 2012 Fourth Quarter Results; Teleconference and Webcast to be held on September 11, 2012
10. Palatin Technologies Provides Update Regarding Its Obesity Research/Development Collaboration with AstraZeneca
11. Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... About Bioactive Material Bioactive ... are increasingly becoming popular due to their ability ... having a negative impact on the human health. ... tissue repair materials in surgical procedures. Bioactive materials ... glass-ceramics, and composites. The major end-users of bioactive ...
(Date:9/23/2014)... France (PRWEB) September 23, 2014 ... of laboratory personnel since 1968 and Burdinola, supplier of ... of a new filtered fume hood. , ... laboratory fume hood, Burdinola will now offer an innovative ... a wide range of chemicals, best-in-class detection technology, and ...
(Date:9/23/2014)... ATCC, the premier global biological materials resource and ... to the senior leadership team. Barbie Bigelow has joined ... and Dr. Maryellen de Mars also joins as the ... are new positions at ATCC. , ... described the additions as part of a revitalization strategy ...
(Date:9/23/2014)... September 23, 2014 Follow ... gaining steady popularity the world over, due to ... Growth in the marketplace is expected to come ... in developing countries. Several sub-Saharan countries in the ... have already implemented genetically engineered crop production strategies. ...
Breaking Biology Technology:Global Bioactive Material Market 2014-2018 2Erlab Partners with Burdinola to Deliver an Innovative Filtered Fume Hood 2ATCC Announces New Appointments to its Leadership Team 2ATCC Announces New Appointments to its Leadership Team 3Rising Focus on Food Security Spurs Growth in the Global Agricultural Biotechnology Market, According to New Report by Global Industry Analysts, Inc. 2Rising Focus on Food Security Spurs Growth in the Global Agricultural Biotechnology Market, According to New Report by Global Industry Analysts, Inc. 3Rising Focus on Food Security Spurs Growth in the Global Agricultural Biotechnology Market, According to New Report by Global Industry Analysts, Inc. 4
... chemical reaction that causes iron to rust plays a similarly ... healthy cells and is a process, scientists know, that contributes ... from Alzheimer,s, heart disease and stroke to cancer and the ... edition (Feb. 21, 2008) of the journal Nature, a team ...
... ... Accuracy, PITTSBURGH, Feb. 20 Applied Isotope Technologies,("AIT") ... edition of the Federal Register as a part of the methods,section of ... Recovery Act). This updated version of the method includes,a long list of ...
... TAMPA, Fla., Feb. 20 Sirion Therapeutics, ... that it has entered into an exclusive ... FL for the worldwide rights to develop ... anti- inflammatory agent norketotifen., (Logo: ...
Cached Biology Technology:Genetic pathway critical to disease, aging found 2Genetic pathway critical to disease, aging found 3Newly Published EPA RCRA Method 6800 Supports AIT Technology 2Sirion Therapeutics Acquires Worldwide License to Develop New Treatment for Ocular Diseases 2
(Date:9/22/2014)... University researchers are studying a potential new treatment that ... in which scars develop in the lungs and severely ... miR-29, which is delivered to lung tissue intravenously. In ... reversed fibrosis after several days. , The findings ... Molecular Medicine . , "The mimic, when injected into ...
(Date:9/22/2014)... Rochelle, NY, September 22, 2014Cassava, also known as tapioca, ... yields in areas of Africa, Asia, and Latin America ... the availability of novel enzymes and processes designed to ... be used to produce sweeteners such as glucose, fructose, ... to corn, as described in a Review article in ...
(Date:9/22/2014)... Antarctic fishes that manufacture their own "antifreeze" ... also suffer an unfortunate side effect, researchers report: ... bodies resist melting even when temperatures warm. ... Proceedings of the National Academy of Sciences . ... undesirable consequence of the evolution of antifreeze proteins ...
Breaking Biology News(10 mins):Reversing the effects of pulmonary fibrosis 2Study: Antifreeze proteins in Antarctic fishes prevent freezingand melting 2Study: Antifreeze proteins in Antarctic fishes prevent freezingand melting 3
... microscopic organ-on-a-chip devices that mimic the way real organs ... effects of therapies more accurately, will be discussed by ... week. Professor Don Ingber, Director of the ... will deliver the inaugural Bagrit Lecture, which will be ...
... Nitrogen pollution in our coastal ecosystems, the result of ... sewage, leads to decreased water transparency, the loss of ... speciessuch as the algae behind the renowned "red tides" ... pronounced in the Gulf of Mexico and the Caribbean. ...
... could a colorblind animal know how to change its ... will the animal,s predator "see," looking at its prey ... are addressed in article published today by a collaborative ... Hole, Mass., and the U.S. Military Academy in West ...
Cached Biology News:Media invitation: Pioneer of organ-on-a-chip technology to speak at Imperial College London 2Sewage-derived nitrogen increasingly polluting Caribbean ecosystems 2How can a colorblind animal change its colors to blend into the background? 2How can a colorblind animal change its colors to blend into the background? 3
... a partial recombinant IFNA2. Immunogen: ... is produced in E. coli. The biological ... OMIM: 147562, ... MM951100564 MA Code: ABV0P9DPB ...
Mouse monoclonal antibody raised against a partial recombinant STAU2. NCBI Entrez Gene ID = STAU2...
Mouse polyclonal antibody to NR2F2 - nuclear receptor subfamily 2, group F, member 2...
Mouse monoclonal antibody raised against a full length recombinant YARS. NCBI Entrez Gene ID = YARS...
Biology Products: